SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is trending following the pricing of a 107 million convertible bond offering, which has sparked intense community debate between those who see it as necessary growth capital for major AI infrastructure projects and those concerned about share dilution. While some investors interpret the institutional participation as a signal of conviction, others remain skeptical about the firm's leadership and the long-term impact on shareholder equity.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending after an unexpected early earnings report that featured the companys highest-ever quarterly net income and a new two billion dollar share repurchase authorization. The community is actively debating the significance of the buyback, with many bulls interpreting the news as a strategic move to squeeze short positions and defend the stock, while others remain skeptical about the firm's pivot toward e-commerce and its recent eBay-related investments.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a massive parabolic rally fueled by a high-profile endorsement from NVIDIA's CEO, who publicly highlighted its potential to reach a trillion-dollar valuation. The community is sharply divided between bulls riding the AI-driven momentum and skepticism from bears who view the move as a speculative gamma squeeze detached from fundamentals.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is trending due to the announcement of a planned 800MW data center campus in South Australia, paired with a major $3.65 billion investment-grade financing deal to support its AI cloud contract with Microsoft. Community sentiment is largely bullish, with investors actively debating the potential for a breakout toward higher price levels as they draw parallels between IREN's infrastructure buildout and successful peer performances in the AI-energy sector.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is seeing intense community focus following a strong earnings report that beat expectations, prompting a wave of bullish analyst upgrades and increased price targets. Investors are actively debating whether the stock's recent performance represents a durable AI-driven growth cycle or if the current valuation has become overextended following a significant pre-earnings rally.

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is seeing significant momentum as investors pivot toward its QNX software platform, which is increasingly viewed as a key player in physical AI and robotics rather than its legacy phone business. The community is actively debating the company's growth trajectory and potential for a squeeze, with many pointing to a growing royalty backlog and institutional accumulation as primary drivers for the recent surge.

LifeVantage Corp. engages in the identification, research, development, formulation, and sale of nutraceutical dietary supplements and personal care products. Its products include Protandim, Axio, TrueScience, PhysIQ, and Petandim. It operates through the Americas, and Asia or Pacific and Europe geographical segments. The company was founded in June 1988 and is headquartered in Lehi, UT.

Lifevantage Corporation

LifeVantage Corporation is generating intense investor interest due to a high-conviction short squeeze setup characterized by an extremely high cost-to-borrow and limited share availability. The community is actively monitoring these tightening liquidity conditions, with many debating if the mounting pressure on short sellers will trigger an explosive move to the upside.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense volatility as investors debate the massive capital expenditure on AI infrastructure, with community sentiment split between those viewing the pullback as a buying opportunity and others concerned over long-term ROI. Market participants are actively discussing Meta's competitive positioning in AI versus peers, with some referencing recent endorsements from industry leaders while others highlight institutional concerns about spending levels and potential share dilution.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is trending as investors react to a lack of communication from new leadership following the company's recent earnings beat, while the community debates whether the ongoing silence from CEO Kevin Tang is a precursor to a potential buyout or a strategic move to suppress share price volatility. Shareholders remain divided on the long-term outlook, weighing the strength of the company's balance sheet and product sales against the frustration of missed communication and the opaque nature of the current management transition.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares (SOXS) is attracting intense attention as retail investors struggle with the relentless, parabolic rise of the semiconductor sector driven by AI-related FOMO and concentrated momentum. The community is actively debating the sustainability of record-breaking sector valuations and the potential for a massive technical correction, while many grapple with the significant decay and losses associated with holding this inverse leveraged ETF in a one-sided bull market.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GSK plc (GSK) Launches Ask2BSure Meningitis Awareness Campaign With Celebrity Advocates

GSK plc (GSK) Launches Ask2BSure Meningitis Awareness Campaign With Celebrity Advocates...

Why Is Glaxo (GSK) Down 2.1% Since Last Earnings Report?

Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

GSK Says Bepirovirsen Achieves Phase III Functional Cure Goal In Chronic Hepatitis B

(RTTNews) - Drugmaker GSK plc (GSK) on Tuesday announced positive Phase III trial results for investigational hepatitis B treatment bepirovirsen...

Here's Why GSK (GSK) is a Strong Value Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Here's Why You Should Add SMMT Stock to Your Portfolio Now

Summit Therapeutics advances ivonescimab with late-stage NSCLC and CRC studies, with FDA review underway and new partnerships expanding its oncology reach.

GSK Stock Declines 9% in a Month: Time to Buy, Hold or Exit?

GSK shares slide after Q1 despite earnings and sales beats, as investors weigh slowing legacy drug sales against strong Specialty Medicines growth.

Ralph Baric And UNC's Biodefense Contract Racket Exposed

Ralph Baric And UNC's Biodefense Contract Racket Exposed Authored by Paul D. Thacker via The DisInformation Chronicle, DLA Piper wants to get you, I was told, from a source in DC over the weekend...

GSK Targets China's Hepatitis B Market Through New Deal

GSK partnered with Sino Biopharmaceutical to advance hepatitis B drug bepirovirsen in China while launching its final buyback tranche.read more...

GSK Launches Final GBP 0.18 Bln Tranche Of GBP 2 Bln Share Buyback

(RTTNews) - GSK plc (GSK, GSK.L, GS71.DE), on Monday announced the commencement of the fifth and final tranche of its 2 billion pounds share buyback program, covering up to about 0.18 billion pounds...

GILD Beats Q1 Earnings and Sales Estimates, Lowers '26 EPS View

GILD beats Q1 estimates as HIV and Trodelvy sales rise, but shares slip after the company cuts its 2026 EPS outlook.

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

GSKGlaxosmithkline plc - ADR

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GSK News